Since BTA and GSK seem to be unable to inform
shareholders, media and analysts
about the decision of the USA to change their stockpile
to a 50-50 ratio of Relenza and Tamiflu, I have done their
work and have sent emails to
- Taylor Collision
- Wilson
- RBS Morgans
and informed them about the fantastic news for Biota
providing the link to HHS-website and underlining that
they find the respective information on pages 179-180.
The link is:
http://www.hhs.gov/aspr/conferences/nbsb/nbsb-mtgtrnscrpt-090925.pdf
I hope this will help that we are protected from further
amateurish reports like the one from Wilson...
It would be great if some of you could to the same so that they cant say that they have not read my email.
The respective analysts are:
[email protected]
[email protected]
Thomas Duthy
[email protected]
[email protected]
[email protected]
It would be fantastic and EXTREMELY useful if some of you
could also inform Autralian newspapers and international
press (Bloomberg etc.) about the new facts.
If we get 1 report in 1 big newspaper/TV etc., then the
rest will follow-up !
If Biota and GSK are not professional enough to inform
poeple about this TRANSFORMATIONAL news for Biota,
we have to do it on our own in order to get a fair
shareprice asap !
Many thanks & best regards from Germany
Eric
inform the media about us relenza stockpile !!
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)